Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Navidea Biopharmaceuticals Inc NAVB

Healthcare Biotechnology
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It is developing multiple precision-targeted products based on its Manocept platform to enhance patient care by identifying the sites and pathways of undetected disease. The Company’s business is focused on... see more

Recent & Breaking News (GREY:NAVB)

Navidea Biopharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results

Business Wire March 7, 2019

Navidea Biopharmaceuticals Schedules Fourth Quarter 2018 Earnings Conference Call and Business Update

Business Wire February 28, 2019

Navidea Biopharmaceuticals Announces Extension of NYSE American Listing

Business Wire February 1, 2019

Navidea Biopharmaceuticals Announces Decision by Ohio Supreme Court

Business Wire January 24, 2019

Navidea Biopharmaceuticals Announces Patent Extension for Lymphoseek®

Business Wire December 7, 2018

Navidea Biopharmaceuticals Appoints Adam Cutler to Board of Directors

Business Wire November 29, 2018

Navidea Biopharmaceuticals Appoints Dr. Michael Rosol as Chief Medical Officer

Business Wire November 29, 2018

Navidea Biopharmaceuticals to Present at the 11th Annual LD Micro Event 2018

Business Wire November 28, 2018

Navidea Biopharmaceuticals Announces Presentation at the Radiological Society of North America (RSNA) 104th Scientific Assembly and Annual Meeting 2018

Business Wire November 27, 2018

Navidea Biopharmaceuticals Appoints Dr. Kathy Rouan to Board of Directors

Business Wire November 26, 2018

Navidea Biopharmaceuticals Reports Third Quarter 2018 Financial Results

Business Wire November 7, 2018

Navidea Biopharmaceuticals Schedules Third Quarter 2018 Earnings Conference Call and Business Update

Business Wire November 1, 2018

Navidea Biopharmaceuticals Wins Dismissal of Platinum Litigation

Business Wire October 31, 2018

Navidea Biopharmaceuticals Receives Acceptance Letter from NYSE American

Business Wire October 30, 2018

Navidea Biopharmaceuticals to Present Data on the Manocept Platform at 2018 ACR Annual Meeting

Business Wire October 11, 2018

Navidea Biopharmaceuticals to Present at the 2018 BIO Investor Forum

Business Wire October 8, 2018

Mid-Morning Market Update: Markets Open Higher; AutoZone Profit Tops Views

Benzinga.com  September 18, 2018

The Daily Biotech Pulse: Morphosys Expands Collaboration, Osiris Announces Product Launch, Argenx To Offer Shares

Benzinga.com  September 18, 2018

22 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  September 18, 2018

Navidea Biopharmaceuticals to Present at 3rd Annual Disruptive Growth & Healthcare Conference Hosted by RHK Capital and ReedSmith

Accesswire May 7, 2018